Question 1

What are the potential benefits of participating in this trial compared to standard treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity clinical trial (NCT02124902). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from docetaxel and carboplatin?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity clinical trial (NCT02124902). Contact the study team or your healthcare provider for specific answers.

Question 3

How often will I need to come in for treatments and tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity clinical trial (NCT02124902). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity clinical trial (NCT02124902). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any additional tests or procedures I need to be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity clinical trial (NCT02124902). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored throughout the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity clinical trial (NCT02124902). Contact the study team or your healthcare provider for specific answers.

What this study is about